Introduction; Summary of economic models assessing pneumococcal vaccines in US

adults; EtR on risk-based use of PCV15 and PCV20 in adults; Considerations for use of PCV15 and PCV20 in adults and next steps

This video can also be viewed at

https://www.cdc.gov/vaccines/videos/low-res/ACIPSept2021/ACIP-3_PneumococcalVaccines_09-29-2021_LowRes.mp4